KEYVIBE-005
Phase 2 Completed
613 enrolled
PLATINUM
Phase 2 Completed
152 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma
Phase 2 Completed
28 enrolled
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
Phase 2 Completed
31 enrolled 8 charts
RATIONALE-309
Phase 3 Completed
263 enrolled 19 charts
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
Phase 2 Completed
34 enrolled
Keynote-122
Phase 3 Completed
233 enrolled 21 charts
A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects
Phase 1 Completed
23 enrolled
Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
Phase 3 Completed
362 enrolled
Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1 Completed
10 enrolled
Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
Phase 2 Completed
80 enrolled
Hepatic Artery Infusion Pump for NPC Liver Metastases
Phase 1 Completed
16 enrolled
Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
Phase 2 Completed
36 enrolled 9 charts
Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
Phase 2 Completed
18 enrolled 9 charts
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Phase 1 Completed
17 enrolled
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
Phase 2 Completed
16 enrolled
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
30 enrolled
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Phase 2 Completed
18 enrolled
A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Phase 2 Completed
26 enrolled 8 charts
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
Phase 2 Completed
50 enrolled
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
Phase 2 Completed
67 enrolled 10 charts
Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck
Phase 2 Completed
21 enrolled
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Phase 2 Completed
41 enrolled